Alofisel for Crohn’s Fistulas Receives EMA Recommendation for Marketing Authorization in EU
News
TiGenix received a European Medicines Agency (EMA) recommendation for the marketing authorization of Alofisel (darvadstrocel, Cx601) as an advanced therapy medicinal product (ATMP) for the treatment of complex perianal fistulas in people with ... Read more